Core Viewpoint - Achieve Life Sciences (ACHV) is a late-stage pharmaceutical company focused on developing a smoking and vaping cessation therapy, currently awaiting FDA approval for its drug candidate [1] Company Overview - ACHV is a pre-commercial company with no sales-generating business at present [1] - The company is actively seeking undervalued stocks with a focus on balancing risk and reward [1] Investment Perspective - There is a belief that the best investment ideas are often the simplest, and a contrarian approach may yield better results [1]